Biotech

All Articles

ArsenalBio raises $325M, rotates out of former lead property

.Collection Biosciences is actually going on up. The tissue therapy firm has added on $325 million i...

Lilly- supported fat loss biotech reports IPO

.After elevating $170 thousand back in February, metabolic disease-focused BioAge Labs has actually ...

Aelis' marijuana use drug flunks stage 2b, steering Indivior to reconsider $100M choice

.Aelis Farma's chances of safeguarding a fast, good decision on a $one hundred million choice settle...

ProKidney standstills phase 3 test certainly not required for cell treatment approval

.ProKidney has quit among a pair of phase 3 tests for its cell treatment for kidney disease after ch...

Vaxcyte surges on 'impressive' 31-valent PCV gain against Pfizer

.Vaxcyte introduced what experts called "magnificent" stage 1/2 records for its own 31-valent pneumo...

Recursion's human brain health condition test reveals little evidence of effectiveness

.Recursion has actually discovered with an early test of its tech-enabled method to drug discovery, ...

Acepodia, Pfizer click on all together for chemistry-based cell treatment

.Contact it a case of great chemistry: Acepodia, a biotech based on Nobel Champion science, is enter...

Praxis epilepsy medicine decreases seizures in period 2 trial

.Praxis Accuracy Medicines has actually racked up another midphase win in epilepsy this year, along ...

Three directors surrender as Dyne messages combined data for DMD prospect

.After running away a medical hold many years back, Dyne Therapeutics has revealed brand new period ...

Arrowhead fires off period 3 records in uncommon metabolic illness before market encounter Ionis

.Arrowhead Pharmaceuticals has actually shown its own hand in advance of a prospective face-off with...